In FY23, women constituted 14% of Taro Pharmaceutical's BOD and 28% of its executives
Register to read the full analysis —or— Upgrade to access more features
#women
#female
#Glass ceiling
#diversity-inclusion
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.